VaxGen, Inc.
Company announces extension of negotiations for HHS anthrax contract award
Published in Nursing Home and Elder Business Week, October 31st, 2004
In a letter to VaxGen dated September 29, 2004, the U.S. Department of Health and Human Services (HHS) stated that, "It is the Government's intention to award a contract on or before October 15, 2004 subject to successful conclusion of negotiations."
The HHS letter asked VaxGen to extend its proposal for providing 75 million doses of its anthrax vaccine candidate "to permit the resolution of administrative issues and to conclude negotiations." VaxGen granted the extension.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Nursing Home and Elder Business Week
More Articles from Nursing Home and Elder Business Week
- BioSante Pharmaceuticals, Inc.
LibiGel significantly increases sexual activity in menopausal women - ForHealth Technologies, Inc.
Florida hospital installs automated robotic intravenous drug preparation system - Medarex, Inc.
Phase I trial to study novel fully human antibody for hospital acquired diarrhea - Medtronic, Inc.
Proposed ruling will broaden access to defibrillators for Medicare patients - OXiGENE, Inc.
Data released on preclinical compound confirming its antitumor activity - Patient Education
Women need to pay attention to their medications - More from this issue of Nursing Home and Elder Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
